FDA Clears 786,000 Jynneos Vaccine Doses Produced In Denmark

By Beth Wang / July 27, 2022 at 3:49 PM
FDA has approved 786,000 doses of Bavarian Nordic’s Jynneos monkeypox vaccine, which were produced at the company’s fill-and-finish facility in Denmark, for use in the United States, HHS and FDA announced Wednesday (July 27). The additional doses will be made available to states and jurisdictions as soon as possible. HHS will announce allocations Thursday (July 28), HHS Secretary Xavier Becerra said. The 786,000 doses are in addition to the 7 million Jynneos doses the government has already purchased, some of...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.